Inventia

  • Industry: Pharmaceuticals
  • Status: Realised (2024)
  • Year of investment: 2020

Inventia

Inventia is a leading manufacturer of oral solid dosage drugs with supplies to over 45 countries.

Supported by a large R&D team, the Company has developed technology platforms to solve complex formulation challenges. The Company has also added nutraceuticals and injectable products to its portfolio.

Inventia’s manufacturing facility is approved by leading regulatory bodies including USFDA.

Scroll to top